Jan-Mangal Pharmacy Foundation Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 21-06-2024
- Paid Up Capital ₹ 0.20 M
as on 21-06-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 4.55%
(FY 2022)
- Profit -24.47%
(FY 2022)
- Ebitda -141.05%
(FY 2022)
- Net Worth 20.36%
(FY 2022)
- Total Assets 13.46%
(FY 2022)
About Jan-Mangal Pharmacy Foundation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ghanshyam Parekh, Hemanshu Kapadia, Dhananjay Desai, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85320GJ2017NPL096400
- Company No.
096400
- Company Classification
Private Not For Profit Company
- Incorporation Date
21 Mar 2017
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Valsad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jan-Mangal Pharmacy Foundation?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ghanshyam Parekh  | Director | 21-Mar-2017 | Current |
| Hemanshu Kapadia | Director | 21-Mar-2017 | Current |
| Dhananjay Desai | Director | 21-Mar-2017 | Current |
| Ashokbhai Patel | Director | 30-Apr-2017 | Current |
| Gautam Parikh | Director | 30-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Jan-Mangal Pharmacy Foundation.
Jan-Mangal Pharmacy Foundation, for the financial year ended 2022, experienced modest growth in revenue, with a 4.55% increase. The company also saw a substantial fall in profitability, with a 24.47% decrease in profit. The company's net worth Soared by an impressive increase of 20.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jan-Mangal Pharmacy Foundation?
Unlock access to Jan-Mangal Pharmacy Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sidmak Laboratories (India) Private LimitedActive 41 years 7 monthsDhananjay Desai is a mutual person
Gelnova Laboratories (India) Private LimitedActive 27 years 11 monthsDhananjay Desai is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jan-Mangal Pharmacy Foundation?
Unlock and access historical data on people associated with Jan-Mangal Pharmacy Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jan-Mangal Pharmacy Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jan-Mangal Pharmacy Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
